Concepedia

An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients

Claudia Sommerer, Barbara Suwelack, Duska Dragun, Peter Schenker, Ingeborg A. Hauser, Oliver Witzke, Christian Hugo, Nassim Kamar, Pierre Merville, Martina Junge,

Kidney International · 2019 · 101 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation

Henrik Ekberg, Hélio Tedesco‐Silva, A. Demirbaş et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

, , +14

Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

B. Sis, Michael Mengel, Mark Haas et al. · American Journal of Transplantation · 2010 · 760 citations · Full text

, , +17

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Klemens Budde, Thomas Becker, Wolfgang Arns et al. · The Lancet · 2011 · 356 citations

, , +14

PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATION

Brian J. Nankivell, Simon M. Gruenewald, Richard D. Allen et al. · Transplantation · 1995 · 293 citations

, , +16

Mycophenolate Mofetil Dose Reduction and the Risk of Acute Rejection after Renal Transplantation

Greg Knoll, Ian Macdonald, Asmat Ullah Khan et al. · Journal of the American Society of Nephrology · 2003 · 286 citations

, , +16